Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Treasury Shares (2023 - 2025)

CorMedix's Treasury Shares history spans 3 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 589.24% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, up 589.24%, while the annual FY2025 figure was $2.0 million, 589.24% up from the prior year.
  • Treasury Shares for Q4 2025 was $2.0 million at CorMedix, up from $291494.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.0 million in Q4 2025 and bottomed at $103735.0 in Q3 2023.
  • The 3-year median for Treasury Shares is $291494.0 (2024), against an average of $801444.0.
  • The largest YoY upside for Treasury Shares was 589.24% in 2025 against a maximum downside of 589.24% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $103735.0 in 2023, then skyrocketed by 181.0% to $291494.0 in 2024, then surged by 589.24% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Treasury Shares are $2.0 million (Q4 2025), $291494.0 (Q4 2024), and $103735.0 (Q3 2023).